Statin Intolerance in Patients With Myocardial Infarction

NCT ID: NCT04069598

Last Updated: 2019-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

600 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-08-26

Study Completion Date

2020-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with acute coronary syndrome (MI, NSTEMI, USAP) will be included. They will be screened for statin intolernace for 6 months.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Statin Adverse Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Statin intolerance test

Statin intolerance test

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute coronary syndrome

Exclusion Criteria

* Being on statin, having statin related side effects
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Turkish Society of Cardiology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Haseki

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Siyami Ersek

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Tepecik

Izmir, , Turkey (Türkiye)

Site Status RECRUITING

Ozcan Basaran

Muğla, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Umit Y Sinan

Role: primary

0212) 459 20 00

Barış Güngör

Role: primary

+90(216) 542 44 44

Oner Ozdogan

Role: primary

+90 232 469 69 69

Ozcan Basaran

Role: primary

+905065359013

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A-HIT 4-SI Study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effective Dose of Statin Post PCI
NCT04923152 COMPLETED NA
Anfibatide Phase Ib-IIa Clinical Trial
NCT01585259 COMPLETED PHASE1/PHASE2
NHLBI Type II Coronary Intervention Study
NCT00000594 COMPLETED PHASE3